What changed in HF 383
The bill as introduced, compared with the version both chambers passed (91st General Assembly).
It passed exactly as introduced.
Removed AddedIntroduced textText as passedAmendments
Compares wording only. The printed bills also mark changes to existing law with strikes and underlines, which aren’t shown here.
Section 1. Section 124.201, Code 2025, is amended by adding the following new subsection:
3 unchanged passages
NEW SUBSECTION.
5.
a. Notwithstanding section 124.204, subsection 4, a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin, also known as COMP 360, or any other trade name approved by the United States food and drug administration, shall be immediately removed from schedule I under section 124.204, subsection 4, paragraph “s”, upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act, 21 U.S.C. §812, and 21 C.F.R. §1308.14.
b. Immediately upon the rescheduling of the drug under paragraph “a”, it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin, also known as COMP 360, or any other trade name approved by the United States food and drug administration.